Martin Brenner I Bio, Inc. (IBIO) insider trading activity

Martin Brenner is Officer of iBio, Inc.. Currently has a direct ownership of 182,502 shares of IBIO, which is worth approximately $375,954. The most recent transaction as insider was on Nov 01, 2023, when has been sold 4,881 shares (Common Stock) at a price of $0.27 per share, resulting in proceeds of $1,317. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 183K

0% 3M change

9.6% 12M change

Total Value Held $375,954

Martin Brenner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2023	SELL Open market or private sale	$1,317 $0.27 p/Share	4,881 Reduced 2.6%	182,502 Common Stock
Oct 03 2023	SELL Open market or private sale	$1,580 $0.3 p/Share	5,267 Reduced 2.73%	187,383 Common Stock
Oct 02 2023	SELL Open market or private sale	$1,306 $0.31 p/Share	4,215 Reduced 2.14%	192,650 Common Stock
Aug 28 2023	SELL Open market or private sale	$1,553 $0.31 p/Share	5,011 Reduced 2.48%	196,865 Common Stock
Jul 27 2023	SELL Open market or private sale	$2,302 $0.51 p/Share	4,515 Reduced 2.19%	201,876 Common Stock
Jul 12 2023	SELL Open market or private sale	$27,741 $0.59 p/Share	47,020 Reduced 18.55%	206,391 Common Stock
Jun 26 2023	BUY Grant, award, or other acquisition	-	75,833 Added 23.03%	253,411 Common Stock
Jun 22 2023	SELL Sale (or disposition) back to the issuer	-	75,833 Reduced 29.92%	177,578 Common Stock
Jun 21 2023	SELL Open market or private sale	$2,845 $0.68 p/Share	4,184 Reduced 1.62%	253,411 Common Stock
May 22 2023	SELL Open market or private sale	$3,931 $0.94 p/Share	4,182 Reduced 1.6%	257,595 Common Stock
Apr 24 2023	SELL Open market or private sale	$5,258 $1.2 p/Share	4,382 Reduced 1.65%	261,777 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	50,000 Added 15.81%	266,159 Common Stock
Mar 23 2023	SELL Open market or private sale	$11,103 $2.13 p/Share	5,213 Reduced 2.35%	216,159 Common Stock
Feb 21 2023	SELL Open market or private sale	$7,037 $1.77 p/Share	3,976 Reduced 1.76%	221,372 Common Stock
Jan 20 2023	BUY Grant, award, or other acquisition	-	130,000 Added 36.58%	225,348 Common Stock
Nov 11 2022	BUY Grant, award, or other acquisition	-	95,348 Added 50.0%	95,348 Common Stock

Also insider at

PFNX

Pfenex Inc.

Chief Scientific Officer

Martin Brenner

Officer

Bryan, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IBIO shares.

Notify only if

Value

Insider Trading

Get notified when an I Bio, Inc. insider buys or sells IBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to iBio, Inc.

Track Activities on IBIO

Account